• Episode #46 - Pioneering Cannabis Bioharmaceuticals with Cannovation Clinical Research Partners, LLC. Lisa Rich Milan and Michael Zaccaria

  • Aug 2 2024
  • Length: 39 mins
  • Podcast

Episode #46 - Pioneering Cannabis Bioharmaceuticals with Cannovation Clinical Research Partners, LLC. Lisa Rich Milan and Michael Zaccaria

Listen for free

View show details

  • Summary

  • In this insightful episode of Roots to Risk, hosts Eric Schneider and Isaac Bock welcome back Lisa Rich Milan, alongside her co-founder Michael Zaccaria, to delve into their groundbreaking new venture, Cannovation Clinical Research Partners, LLC.

    Shifting from the traditional CPG discussions, this episode explores the innovative biotech and pharmaceutical approaches to cannabis. Lisa and Michael share their vision of expediting drug discovery and bringing cannabis-related medical products to market, shedding light on regulatory challenges, the impact of rescheduling cannabis to a Schedule III substance, and the promising future of cannabis in the pharmaceutical landscape.

    Tune in to learn about the intersection of cannabis, biotech, and the potential for significant advancements in medical treatments.
    Show More Show Less
Show More Show Less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Episode #46 - Pioneering Cannabis Bioharmaceuticals with Cannovation Clinical Research Partners, LLC. Lisa Rich Milan and Michael Zaccaria

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews
No Reviews are Available